These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 17393957)
1. Update on the use of antiplatelet agents in secondary stroke prevention. Jamieson DG J Natl Med Assoc; 2007 Mar; 99(3):306. PubMed ID: 17393957 [No Abstract] [Full Text] [Related]
2. Antiplatelet therapy in populations at high risk of atherothrombosis. Faxon DP; Nesto RW J Natl Med Assoc; 2006 May; 98(5):711-21. PubMed ID: 16749646 [TBL] [Abstract][Full Text] [Related]
4. Counting the true cost of antiplatelet therapy for stroke prevention. Morton JA; Newton J; Gray CS Age Ageing; 2005 May; 34(3):212-4. PubMed ID: 15863405 [No Abstract] [Full Text] [Related]
5. Newer antiplatelet therapies in stroke prevention. Davis SM; Donnan GA Aust Fam Physician; 2001 Feb; 30(2):129-34. PubMed ID: 11280112 [TBL] [Abstract][Full Text] [Related]
6. [Secondary stroke prevention according to the PRoFESS Study. What are the sequelae for practical therapy?]. Diener C MMW Fortschr Med; 2008 May; 150(21):7. PubMed ID: 18578065 [No Abstract] [Full Text] [Related]
7. Antiplatelet agents for stroke prevention. Paciaroni M; Gallai V Cerebrovasc Dis; 2000; 10 Suppl 4():36-9. PubMed ID: 11070399 [No Abstract] [Full Text] [Related]
9. Antiplatelet therapies for secondary stroke prevention: an update on clinical and cost-effectiveness. Rothlisberger JM; Ovbiagele B J Comp Eff Res; 2015 Aug; 4(4):377-84. PubMed ID: 26274799 [TBL] [Abstract][Full Text] [Related]
10. Antiplatelet therapy to prevent recurrent stroke: Three good options. Mansoor AH; Mujtaba MT; Silver B Cleve Clin J Med; 2013 Dec; 80(12):787-95. PubMed ID: 24307163 [TBL] [Abstract][Full Text] [Related]
11. Aspirin should be first-line antiplatelet therapy in the secondary prevention of stroke. Warlow C Stroke; 2002 Aug; 33(8):2137-8. PubMed ID: 12154276 [No Abstract] [Full Text] [Related]
12. [Antiplatelet therapy of secondary stroke prevention after ESPS-2 and CAPRIE]. Alvarez-SabĂn J; Montaner-Villalonga J Rev Neurol; 1999 Oct 16-31; 29(8):780-4. PubMed ID: 10560115 [TBL] [Abstract][Full Text] [Related]
13. Does the combination of warfarin and aspirin have a place in secondary stroke prevention? Yes. Furlan AJ Stroke; 2009 May; 40(5):1942-3. PubMed ID: 19299635 [No Abstract] [Full Text] [Related]
14. Antiplatelet agents for secondary prevention of ischemic stroke. Majid A; Delanty N; Kantor J Ann Pharmacother; 2001 Oct; 35(10):1241-7. PubMed ID: 11675854 [TBL] [Abstract][Full Text] [Related]
15. [Platelet-function inhibitors in the secondary prevention of ischemic stroke]. Busse O; Diener HC; Grond M Dtsch Med Wochenschr; 2006 Nov; 131 Suppl 5():S132-4. PubMed ID: 17089258 [No Abstract] [Full Text] [Related]
16. Current guidelines on antiplatelet agents for secondary prevention of noncardiogenic stroke: an evidence-based review. Simmons BB; Yeo A; Fung K; ; Postgrad Med; 2010 Mar; 122(2):49-53. PubMed ID: 20203455 [TBL] [Abstract][Full Text] [Related]